AI and human collaboration in Health
Explore the perspectives of 600 healthcare and life sciences professionals on the potential and value of AI, based on research revealed in an Avanade AI Readiness Report.
AI study uncovers Microsoft Copilot perceived value
According to the research, there is a willingness across executive and line of business roles to elevate the workplace experience with Microsoft Copilot.
More than any other industry, 28% of healthcare respondents and 25% in life sciences believe an AI copilot will reduce their workload. The research also points out that organizations believe they will need help to skill up employees to use AI safely and effectively.
Healthcare and life sciences professionals increasingly turning to AI
AI is proving transformative in modern health care delivery. From natural language processing to deep learning and machine learning, AI can enhance human decision-making and turn “smart” tasks like learning and reasoning into game-changing tools and technologies for patients, providers and researchers. Healthcare and life science leaders are increasingly turning to AI capabilities to streamline processes, reduce costs and improve outcomes and patient experience. In fact, according to the research, 56% of healthcare and life science professionals use AI daily in their current roles.
Top use cases help organizations invest in AI
Globally, most healthcare leaders view AI as a partner for improving access to care for patients and making the experience as seamless as possible. In life sciences, clinical trials and supply chain efficiency are ranked paramount to ensure the timely and reliable delivery of critical pharmaceuticals, medical devices, and other healthcare products.
Ninety-seven percent of healthcare and life science professionals said that investments in AI will be increasing up to 26% and 56% reported using AI daily in their current roles.
54
%
for life science professionals in decentralized clinical trials and supply chain efficiency and accuracy
67
%
is the top use case worthy of future investment for healthcare professionals
60
%
are the top digital investment for scaling AI throughout the organization
90
%
is believed to be the main impact of AI on people focused processes and roles
Ready or not: generative AI is here
Read the full report now
New global research from Avanade explores the readiness of organizations to introduce, adopt and scale generative AI tools like Microsoft Copilot.
Want to talk to an expert?
Headquarters
North America
1191 Second Avenue
Suite 100
Seattle, WA 98101
Europe
30 Fenchurch Street
London
EC3M 3BD
Growth Markets
Avanade Asia Pte Ltd
250 North Bridge Road
#30-03 Raffles City Tower
Singapore 179101